Retatrutide is still in trials and not FDA approved, she notes, yet some college students are getting it from online sellers anyway.
Recap by typeshit. Post by @drsherylatgoodinside on Instagram.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A surgeon on social media says the FDA has received two death reports involving black-market retatrutide. No official FDA statement is linked.
Roy's source notes point to work by Gomez-Banoy, Cohen and colleagues reviewing cancer care scans taken from 2009 to 2024. The study's GLP-1 link isn't spelled out in the snippet.
Shea reports all four known activators sat deep in the receptor pocket while both blockers stayed farther out, the same pattern as his first small test.
Loading…